Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.78 +0.22 (+0.86%)
Official Closing Price Updated: 7:00 PM EDT, Jul 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 39,499,547
Open 25.58
Bid (Size) 25.82 (1)
Ask (Size) 26.00 (8)
Prev. Close 25.56
Today's Range 25.54 - 26.05
52wk Range 20.91 - 31.54
Shares Outstanding 5,606,688,356
Dividend Yield 6.67%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GSK Stock Gains As Flu Vaccine Rollout Begins And US Recovers From Most Severe Season In 15 Years
Fluarix and Flulaval are being shipped in single-dose, 0.5 mL pre-filled syringes and are not recommended for individuals with severe allergies to vaccine components or a history of Guillain-Barré... 
Via Stocktwits
Topics Death Lawsuit
Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study
Xtandi plus leuprolide improved overall survival in prostate cancer patients in the Phase 3 EMBARK trial, with no new safety concerns reported. 
Via Benzinga

Performance

YTD
-3.1%
-3.1%
1 Month
+6.1%
+6.1%
3 Month
+19.4%
+19.4%
6 Month
-3.5%
-3.5%
1 Year
-9.1%
-9.1%

More News

Read More
An Investor Wonders Why Trump's Tariffs Aren't Shaking The Markets. 'Does Wall Street Simply Not Care About The Economy Anymore?'
Via Benzinga
Topics Economy Government
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months
Via Benzinga
Topics Intellectual Property
Should Politicians Be Allowed to Trade Stocks? The Big Debate
Via MarketMinute
Topics Artificial Intelligence Electric Vehicles
A Message to All Investors From Motley Fool CEO Tom Gardner
Via The Motley Fool
Topics Artificial Intelligence
XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
From Pfizer Inc.
Via Business Wire
This Is the No. 1 Ultra-High-Yield Dividend Stock Held by Retail Investors on Robinhood -- and It's Not Even Close
Via The Motley Fool
Topics ETFs
Warren Buffett's Quiet Dividend Play: 9 High-Yield Stocks Held By A Berkshire Subsidiary
Via Benzinga
These S&P500 stocks are the most active in today's session
Via Chartmill
3 Disappointing Blue Chip Stocks That Have Crashed as Much as 87% in 10 Years
Via The Motley Fool
Topics Intellectual Property
Options Corner: Bullish Traders Eye Eli Lilly As Market Signals Hint At A Turnaround
Via Benzinga
Top 5 Undervalued Dividend Stocks With Strong Payout Potential
Via MarketBeat
3 No-Brainer Stocks to Buy in July
Via The Motley Fool
Warren Buffett Owns 9 Ultra-High-Yield Dividend Stocks. Here's the Best of the Bunch.
Via The Motley Fool
Topics ETFs Regulatory Compliance
The Best Dividend Stocks I'd Buy Right Now
Via The Motley Fool
2 Stocks to Buy With Less Than $50
Via The Motley Fool
Topics Intellectual Property
Trump's 'Big, Beautiful Bill' Hands $5 Billion Win To Big Pharma: Report
Via Benzinga
Topics Government
Prediction: 3 Magnificent Stocks That'll Be Worth More Than Palantir by 2028
Via The Motley Fool
Topics Artificial Intelligence
3 Safe-and-Steady Stocks on Our Watchlist
Via StockStory
Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session.
Via Chartmill
RFK Jr. Influence Evident As Vaccine Chief Overrules Scientists, Limits COVID-19 Vaccine Approval
Via Benzinga
Recent Report Shows That Sen. Ron L Wyden Sold Up to $15K Worth of Pfizer Stock
Via Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Is Pfizer Stock a Yield Trap?
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 25.78
When was Pfizer last traded?
The last trade of Pfizer was at 07/10/25 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 144.54B
How many shares of Pfizer are outstanding?
Pfizer has 145B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.